US Patent Issued to Regents of the University of Minnesota on Oct. 14 for "Compositions and methods for treating serpin B13 disorders" (Minnesota Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,811, issued on Oct. 14, was assigned to Regents of the University of Minnesota (Minneapolis).

"Compositions and methods for treating serpin B13 disorders" was invented by Jan Czyzyk (Minneapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are anti-OVA-serine proteinase inhibitor (serpin) B13 monoclonal antibodies and antigen-binding antibody fragments that selectively and specifically bind to an epitope of serpin B13, compositions containing these antibodies and antibody fragments, and methods of using these antibodies and antibody fragments. These antibodies and antigen-binding fragments thereof are useful for inhibiting serpin B...